Research In Brief

Targeted muscle reinnervation in prosthetic arms: Amputees' remaining arm muscles can be "reinnervated" to produce enough signals to control an artificial arm in real time, according to data from five patients treated at the Rehabilitation Institute of Chicago published in the Feb. 11 Journal of the American Medical Association. In the study, five people with shoulder disarticulation or transhumeral amputations underwent targeted muscle innervations; transfer of the remaining arm nerves to residual chest or upper-arm muscles transforms the muscles into "biological amplifiers" of motor commands from the transferred nerves. The target muscles produce electromyogram signals on the surface of the skin that can control an artificial elbow, wrist and hand, according to study author Todd A. Kuiken, M.D./Ph.D., Neural Engineering Center for Artificial Limbs, et al. The patients in the study were able to repeatedly perform 10 different elbow, wrist and hand motions with their artificial arm. The mean motion selection and motion completion times for elbow and wrist movements were 0.22 seconds and 1.29 seconds, respectively. These times were only 0.06 seconds and 0.21 seconds longer than the mean time for five non-amputee patients enrolled as the control group. In an accompanying editorial, Gerald E. Loeb, University of Southern California's Departments of Biomechanical Engineering and Neurology, calls Kuiken's results "exciting and promising." Loeb adds: "Such revolutions develop slowly at best, but their effects tend to be profound. With increasing functional capabilities, patients with upper-extremity amputations may derive exceptional benefit from prosthetic arms, just as legions of patients with lower-extremity amputations now lead remarkably normal and even athletic lives.

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Archive

  • Iran Deal In Place, But API Prices Stay Elevated And Pharma Supply Chains Face A Slow Recovery

    A framework to end the Iran war is in place but fractured supply chains can’t recover overnight. Data from India suggests solvent prices have generally cooled from April peaks, but API costs stay elevated or even climbed in June for some products.

  • Cardiac catheter reuse targeted by FDA; lab testing of used catheters planned.

    REUSE OF DISPOSABLE CARDIAC CATHETERS TARGETED BY FDA in an effort to address safety concerns about reuse of single-use products. The cardiac catheter product area "seems to jump up as one that is an area for us to focus on," Larry Spears, director of the Office of Compliance's Division of Enforcement III in FDA's Center for Devices and Radiological Health, said June 24 at a Food Drug and Law Institute conference held in Washington, D.C.

  • Heart valve sewing cuffs to be developed:

    St Jude Medical and Spire are to develop anti-bacterial heart valve sewing cuffs using Spire's Spi-Argent silver coating process. The agreement covers a variety of valve designs as well as ancillary components. The treatment is aimed at reducing the incidence of endocarditis, a rare but dangerous complication of valve transplant which has a mortality rate as high as 60%.

  • Nissho sales flat at only 1% in 1997:

    Nissho saw sales rise only 1% to ¥17 billion ($930 million) in the year to March 1997. The Japanese company's net income was Yen3 billion, compared with Yen1.7 billion for the previous year, reports Reuters. Nissho produces disposable medical equipment.

More from Medtech Insight